Swiss drugmaker Novartis has signed a licensing deal worth nearly $1.7 billion with privately held SciNeuro Pharmaceuticals ...
The New Orleans Jewish Community Center’s Alzheimer's Care and Enrichment Program has become a lifeline for families dealing ...
Giving away money is common in individuals with Alzheimer's or dementia. Whether it is writing checks to various charities or ...
Open-angle glaucoma is linked to an increased risk for early-onset Alzheimer’s disease in middle-aged adults, especially men, ...
Researchers have added to a stack of existing evidence that 40 Hz gamma frequencies could help to treat Alzheimer's disease.
Researchers have discovered a brain activity pattern that can predict which people with mild cognitive impairment are likely ...
Alamar Biosciences, Inc. ('Alamar'), a leader in precision proteomics dedicated to advancing the early detection of disease, ...
While a blood test to look for Alzheimer’s is a monumental leap, and is a great source of hope, we need to remember that a ...
A new drug candidate shows promise by reversing cognitive decline in advanced Alzheimer's disease by restoring brain balance ...
The Alzheimer’s Foundation of America (AFA) is inviting all high school seniors affected by dementia-related illnesses to ...
New research shows that aging blood can accelerate Alzheimer’s-like changes in the brain, while younger blood may offer ...
Singaporean scientists have identified a possible early marker of Alzheimer's disease associated with disruption of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results